Hans Kieft

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial

Evelien de Jong, Jos A van Oers, Albertus Beishuizen et al. · The Lancet Infectious Diseases · 2016 · 789 citations · Full text

Antibiotic Treatment, Open-label Trial, Critical Care Medicine +10

Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial

René Post, Menno R. Germans, Maud A. Tjerkstra et al. · The Lancet · 2020 · 184 citations · Full text

Subarachnoid Hemorrhage, Sepsis, Intracranial Pressure +7

Clinical outcome of immunonutrition in a heterogeneous intensive care population

Hans Kieft, Arnout N. Roos, J.D.E. Van Drunen et al. · Intensive Care Medicine · 2005 · 132 citations

Critical Care Management, Critical Care Medicine, Acute Care +6

The Sepsis Syndrome in a Dutch University Hospital

Hans Kieft · Archives of Internal Medicine · 1993 · 97 citations

Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands

Dave A. Dongelmans, Fabian Termorshuizen, Sylvia Brinkman et al. · Annals of Intensive Care · 2022 · 86 citations · Full text